Leap Therapeutics Statistics

Total Valuation

LPTX has a market cap or net worth of $111.51 million. The enterprise value is $49.06 million.

Market Cap	111.51M
Enterprise Value	49.06M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

LPTX has 38.32 million shares outstanding. The number of shares has increased by 105.89% in one year.

Current Share Class	38.32M
Shares Outstanding	38.32M
Shares Change (YoY)	+105.89%
Shares Change (QoQ)	+5.33%
Owned by Insiders (%)	0.93%
Owned by Institutions (%)	25.81%
Float	25.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.27
P/TBV Ratio	2.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.01.

Current Ratio	3.97
Quick Ratio	3.95
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -107.18% and return on invested capital (ROIC) is -70.64%.

Return on Equity (ROE)	-107.18%
Return on Assets (ROA)	-58.05%
Return on Capital (ROIC)	-70.64%
Revenue Per Employee	n/a
Profits Per Employee	-$1.20M
Employee Count	54
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, LPTX has paid $708,000 in taxes.

Income Tax	708,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.69% in the last 52 weeks. The beta is 0.15, so LPTX's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-1.69%
50-Day Moving Average	3.07
200-Day Moving Average	2.66
Relative Strength Index (RSI)	47.52
Average Volume (20 Days)	455,061

Short Selling Information

The latest short interest is 1.42 million, so 3.72% of the outstanding shares have been sold short.

Short Interest	1.42M
Short Previous Month	1.42M
Short % of Shares Out	3.72%
Short % of Float	5.50%
Short Ratio (days to cover)	2.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.78M
Pretax Income	-53.37M
Net Income	-64.82M
EBITDA	-68.77M
EBIT	-68.78M
Earnings Per Share (EPS)	-$1.91

Full Income Statement

Balance Sheet

The company has $62.82 million in cash and $376,000 in debt, giving a net cash position of $62.45 million or $1.63 per share.

Cash & Cash Equivalents	62.82M
Total Debt	376,000
Net Cash	62.45M
Net Cash Per Share	$1.63
Equity (Book Value)	48.95M
Book Value Per Share	1.28
Working Capital	47.72M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-55.17M
Capital Expenditures	n/a
Free Cash Flow	-55.17M
FCF Per Share	-$1.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LPTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-105.89%
Shareholder Yield	-105.89%
Earnings Yield	-58.13%
FCF Yield	-49.47%

Analyst Forecast

The average price target for LPTX is $7.50, which is 157.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	157.73%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-34.80%

Stock Forecasts

Stock Splits

The last stock split was on June 21, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jun 21, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1